SOX2 and breast cancer: The expression of SLC6A14 also exhibited a positive correlation with the level of SOX2 in tumors with an odds ratio of 4.40 (p‐value = 0.012) (Figure 5K and Table S5, Supporting Information) and the hair level of DEHP in breast cancer patients (Figure 5L).